RESTON, Va., Feb. 25, 2026 (GLOBE NEWSWIRE) — Lightbridge Corporation (“Lightbridge” or the “Company”) (Nasdaq: LTBR), an advanced nuclear fuel technology company, announced its financial results for the fiscal year ended December 31, 2025, and provided an update on the Company’s continued progress. Seth Grae, President & Chief Executive Officer of Lightbridge Corporation, commented, “2025 was an important year for Lightbridge and the nuclear power industry. Governments, utilities, and leading tech companies agree with our conclusion that reliable, clean nuclear power is necessary to meet the growing demand for electricity from AI and data centers, address rising energy costs, and help achieve energy independence.” “In 2025, we reached key milestones in our fuel development program. Our team, in collaboration with Idaho National...

2025 reported diluted EPS were $2.92 versus $2.87 in 2024. On an adjusted (non-GAAP) basis, 2025 diluted EPS of $2.99 came in near the top of our upwardly narrowed $2.95 to $3.001 guidance range, compared to $2.95 in 2024 Establish a 2026-30 capital expenditures budget of $2.7 billion, a 31% increase over the prior five-year plan, to fund needed infrastructure replacement, PFAS remediation, additional water supplies, and investments in the Quadvest, L.P. system following the anticipated mid-2026 close Initiate 2026 standalone adjusted diluted EPS guidance of $3.08-3.181 (excludes the impacts of the pending Quadvest acquisition and the financing thereof) Increase long-term adjusted diluted EPS CAGR target to 6-8%; expect to deliver a non-linear CAGR at or above the top end of the 6-8% range over the 2026-30 period (includes the impacts...

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) — Chemed Corporation (Chemed) (NYSE: CHE), which operates VITAS Healthcare Corporation (VITAS), the nation’s largest providers of end-of-life care, and Roto-Rooter, the nation’s largest commercial and residential plumbing and drain cleaning services provider, reported financial results for its fourth quarter ended December 31, 2025, versus the comparable prior-year period. Results for Quarter Ended December 31, 2025 Consolidated operating results:Revenue was $639.3 million, essentially flat with the fourth quarter of 2024 GAAP Diluted Earnings-per-Share (EPS) of $5.48, a decrease of 9.0% Adjusted Diluted EPS of $6.42, a decrease of 6.0%VITAS segment operating results:Net Patient Revenue of $418.8 million, an increase of 1.9% Average Daily Census (ADC) of 22,462, an increase of 1.3% Admissions...

CINCINNATI, Feb. 25, 2026 (GLOBE NEWSWIRE) — The E.W. Scripps Company (NASDAQ: SSP) delivered $560 million in revenue for the fourth quarter of 2025. Loss attributable to the shareholders of Scripps was $44.9 million or 51 cents per share. Business notes:The company has launched a transformation plan that targets annualized enterprise EBITDA growth of $125-$150 million by 2028 through cost savings and revenue growth initiatives that will leverage technology including AI and automation to increase the yield on its existing businesses. Financial benefits from the transformation initiatives will begin to flow in during the back half of 2026 and are expected to contribute to a significantly improved leverage ratio by year-end. In the Local Media division, core advertising revenue was up 12% in the fourth quarter. All five top core...

HOUSTON, Feb. 25, 2026 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced its operating and financial results for the fourth quarter and full year of 2025. Whitestone creates neighborhood center communities in its high-quality open-air shopping centers that it acquires, owns, manages, develops, and redevelops primarily in some of the largest, fastest-growing, high-household-income markets in the Sunbelt. For the three months ended December 31, 2025 and 2024, Net income attributable to common shareholders per diluted share was $0.43 and $0.33, respectively. For the full year 2025 and 2024, Net income attributable to common shareholders per diluted share was $0.95 and $0.72, respectively. “We are pleased to report strong fourth quarter and full year operating and financial results. We delivered...

SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) — California Water Service Group (Group or Company, NYSE: CWT), a leading publicly traded water utility serving California, Hawaii, New Mexico, Washington, and Texas, today reported solid Q4 and year-end 2025 results and provided an update on the Proposed Decision in its 2024 California General Rate Case (2024 CA GRC). Fourth Quarter and Year-End 2025 Results in Line with Expectations; Impacted by Wet Q4 Weather Q4 Financial Results Q4 2025 net income decreased $8.2 million, or 42%, to $11.5 million, or $0.19 per diluted share, compared to net income of $19.7 million, or $0.33 per diluted share in Q4 2024. Q4 2025 revenue decreased $2.2 million, or less than 1.0%, to $220.0 million, compared to revenue of $222.2 million in Q4 2024.Rate changes and changes in the Monterey-Style...

THORNTON, Colo., Feb. 25, 2026 (GLOBE NEWSWIRE) — MYR Group Inc. (“MYR” or the “Company”) (NASDAQ: MYRG), a holding company of leading specialty contractors serving the electric utility infrastructure, commercial and industrial construction markets in the United States and Canada, announced today its fourth-quarter and full year 2025 financial results. Fourth Quarter 2025 HighlightsQuarterly revenues of $973.5 million Record quarterly net income of $36.5 million, or $2.33 per diluted share Record quarterly EBITDA of $64.2 millionFull Year 2025 HighlightsRecord full-year revenues of $3.66 billion Record full-year net income of $118.4 million, or $7.53 per diluted share Record full-year EBITDA of $232.7 million Record backlog of $2.82 billionManagement CommentsRick Swartz, MYR’s President and CEO, said, “We closed...

Full Year 2025 Total Revenues of $589.0 Million, Representing 19.8% Year-Over-Year Growth and Marking Another Year of Record Total Revenues Q4 2025 Total Revenues of $152.6 Million, Fueled by 18.3% FIRDAPSE® (amifampridine) Growth and 67.5% Growth of AGAMREE® (vamorolone), Reflecting Continued Adoption Full Year 2026 Total Revenues Expected to be Between $615 Million and $645 Million, Reflecting Confidence in Strength and Durability of FIRDAPSE and AGAMREE Franchises Promoted Product Revenue, Net Expected to Grow by 20% or More in 2026 Conference Call and Webcast to be Held on February 26, 2026, at 8:30 AM ET CORAL GABLES, Fla., Feb. 25, 2026 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX) today reported financial results for fourth quarter and full year 2025 and provided full year 2026...

FY2025 in line with guidance Operational turnaround and transformation on track FY 2025 results, including MeTS:€4.5B Group revenue1, -2.4% organically vs 2024 (guidance of low single digit percentage decline) €841M adjusted EBITDA1, 18.7% adj EBITDA margin (guidance at €830m to €855m) €(9)M free cash flow12 (guidance at €-30M to €0M+) with €(49)M in H2 2025 Net result at €(5,157)M Group Share including €(4,647)M impairments of goodwill Normalised net results at €175MExcluding MeTS (under IFRS53) revenues, adjusted EBITDA and free cash flow respectively amount to €4.0B, €737M and €(26)M Turnaround and transformation on trackImproved churn in all geographies and improved order intake and pipeline in financial services in Q4 2025 Transformation initiatives operationalized with benefits in Q4 2025 and clear milestones for 2026 Pruning...

FULL-YEAR RESULTS FOR 2025DERISKED, DELEVERAGED BALANCE SHEETCONSOLIDATION OF LEADERSHIP POSITIONFURTHER IMPROVEMENT IN OPERATING PROFITABILITY AND LEVERAGE RATIO IN 2026Nexity ready to rebound: Operational momentum and financial discipline evident in results for 2025Derisked, deleveraged balance sheet:Net financial debt at �278m ahead of the increase in the shareholding in Angelotti, representing a �52m reduction in debt (vs net financial debt of �330m in 2024); Group net financial debt of �328m at year-end 2025, equating to Group debt being halved in 2 years Free cash flow positive in 2025, with �107m in operating free cash flow Opportunistic decisions, with accounting impacts on net profit, reflected in the generation of free cash flow over the full yearCurrent operating profit/(loss) (COP)1 equating to net profit of �25m...